American Journal of Epidemiology Vol. 110, No. 2: 196-204
Copyright © 1979 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
DRUG UTILIZATION AND REPORTED ADVERSE REACTIONS IN HOSPITALIZED CHILDREN
1 Clinical Pharmacology Unit, Children's Hospital Medical Center, the Departments of Pediatrics and Pharmacology, Harvard Medical School, the Center for the Analysis of Health Practices, Harvard School of Public Health
2 The Drug Epidemiology Unit, Boston University Medical Center Boston, MA
Reprint requests to Dr. Mitchell, Children's Hospital Medical Center, 300 Longwood Ave., Boston, MA 02115
An intensive drug surveillance program has been developed to study the clinical effects of drugs in hospitalized children. This program collects information on drug exposures and the occurrence of adverse clinical events. The 1669 children monitored to date received an average of 7.6 drugs during an average hospital stay of 8.4 days. A group of specified adverse clinical events, whether or not drug attributed, occurred in 45.7% of the patients; drug-attributed events (adverse drug reactions) occurred in 16.8%. Both drug use and reported adverse reactions tended to increase with age, except that newborns received many drugs but had the lowest reported adverse reaction rates. Newborns, however, had the highest rate of adverse events not attributed to drugs, suggesting that perhaps some of these latter events include presently unrecognized adverse drug reactions.
drug evaluation; drug utilization; pediatrics
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Le, T. Nguyen, A. V. Law, and J. Hodding Adverse Drug Reactions Among Children Over a 10-Year Period Pediatrics, August 1, 2006; 118(2): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lazarou, B. H. Pomeranz, and P. N. Corey Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA, April 15, 1998; 279(15): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fosarelli, M. Wilson, and C. DeAngelis Prescription Medications in Infancy and Early Childhood Arch Pediatr Adolesc Med, July 1, 1987; 141(7): 772 - 775. [Abstract] [PDF] |
||||
![]() |
C. Louik, A. A. Mitchell, M. F. Epstein, and S. Shapiro Risk Factors for Neonatal Hyperglycemia Associated With 10% Dextrose Infusion Arch Pediatr Adolesc Med, August 1, 1985; 139(8): 783 - 786. [Abstract] [PDF] |
||||
![]() |
A. A. Mitchell, P. G. Lacouture, and R. K. Crone Accidental Administration of Ergonovine to a Newborn JAMA, August 12, 1983; 250(6): 730 - 731. [Abstract] [PDF] |
||||
![]() |
P. G. LACOUTURE, F. H. LOVEJOY JR, and A. A. MITCHELL Acute Hypothermia Associated With Atropine Arch Pediatr Adolesc Med, March 1, 1983; 137(3): 291 - 292. [Abstract] [PDF] |
||||
![]() |
A. A. Mitchell, F. H. Lovejoy Jr, D. Slone, and S. Shapiro Acetaminophen and Aspirin: Prescription, Use, and Accidental Ingestion Among Children Arch Pediatr Adolesc Med, November 1, 1982; 136(11): 976 - 979. [Abstract] [PDF] |
||||
![]() |
A. A. Mitchell, C. Louik, P. Lacouture, D. Slone, P. Goldman, and S. Shapiro Risks to Children From Computed Tomographic Scan Premedication JAMA, May 7, 1982; 247(17): 2385 - 2388. [Abstract] [PDF] |
||||


